T88 Shares Taiton Resources Limited
ASX · ASXLast in our picks 2026-10-04 — not in the current list; analysis below is from that screen
Multiple regulatory catalysts create asymmetric upside for this early-stage biotech.
Signal breakdown
- ▸FDA clearance and pivotal-trial milestones ahead.
- ▾Below 50-day MA (-1.74%)
- ▾Near 52-week low (8.1% of range)
Is T88 a buy right now?
Trend: T88 is trading above the 50-day average (+8.00%), RSI 21 — oversold territory, with a 3-month return of +38.46%.
Valuation & quality: Taiton Resources Limited trades on price-to-book 1.20; fundamentals show net margin 0.0%, return on equity -31.2%, revenue growth 146.2% year on year.
Our screen: BUY (score 2) — Multiple regulatory catalysts create asymmetric upside for this early-stage biotech.
Computed from end-of-day data; not personal advice.
12-month price chart
Monthly returns
| Mar 26 | Apr 26 | May 26 | Jun 26 | Jul 26 | Aug 26 | Sep 26 | Oct 26 |
|---|---|---|---|---|---|---|---|
| +0.00% | -22.20% | -14.30% | -50.00% | +33.30% | +25.00% | -20.00% | +25.00% |
Fundamentals
Technical signals
About Taiton Resources Limited
Taiton Resources Limited engages in the exploration, and evaluation of mineral tenements in Australia. The company explores molybdenum, quartz, gold, uranium, and rare earth element deposits.
Sector: Basic Materials · Industry: Other Precious Metals & Mining · Australia · Website
Related Biotech picks
Browse: all ASX stocks · Biotech picks · today's movers
Market data from end-of-day feeds; AI-generated research for educational purposes only — not investment advice.